1355 related articles for article (PubMed ID: 8155255)
1. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
2. Proteins spontaneously released by rat insulinoma (RIN) cells are anchored on cell membrane by a glycosyl-phosphatidyl-inositol link and inhibit increased RIN cell adhesion of lymphocytes from type 1 diabetic patients and non-obese diabetic mice in vitro.
Gouin E; Segain JP; Saï P
Diabetes Metab; 1996 Dec; 22(6):439-50. PubMed ID: 8985653
[TBL] [Abstract][Full Text] [Related]
3. Splenocytes from non-obese-diabetic mice binding to xenogeneic beta-cells in vitro: an early marker of cell-mediated immunity.
Martignat L; Feve B; Charbonnel B; Sai P
Diabete Metab; 1993; 19(6):566-74. PubMed ID: 8026608
[TBL] [Abstract][Full Text] [Related]
4. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW; Barber L; Chen KE; Alters SE
J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
[TBL] [Abstract][Full Text] [Related]
5. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
6. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
7. Peri-islet infiltrates of young non-obese diabetic mice display restricted TCR beta-chain diversity.
Galley KA; Danska JS
J Immunol; 1995 Mar; 154(6):2969-82. PubMed ID: 7533189
[TBL] [Abstract][Full Text] [Related]
8. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
[TBL] [Abstract][Full Text] [Related]
9. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice.
Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546
[TBL] [Abstract][Full Text] [Related]
10. Establishment of T-cell lines from infiltrated NOD islets by stimulation of specific T-cell receptor V beta segments.
Maugendre D; Legrand B; Olivi M; Bedossa P; Bach JF; Carnaud C
J Autoimmun; 1993 Aug; 6(4):423-36. PubMed ID: 8105789
[TBL] [Abstract][Full Text] [Related]
11. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
Serreze DV; Chapman HD; Varnum DS; Gerling I; Leiter EH; Shultz LD
J Immunol; 1997 Apr; 158(8):3978-86. PubMed ID: 9103469
[TBL] [Abstract][Full Text] [Related]
12. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
13. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
[TBL] [Abstract][Full Text] [Related]
14. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a preferential V beta usage by the T cells which adoptively transfer diabetes in NOD mice.
Edouard P; Thivolet C; Bedossa P; Olivi M; Legrand B; Bendelac A; Bach JF; Carnaud C
Eur J Immunol; 1993 Mar; 23(3):727-33. PubMed ID: 8095459
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the T-cell receptor V beta 5 and V beta 8 repertoire in pancreatic lesions of autoimmune diabetic NOD mice.
Berschick P; Fehsel K; Weltzien HU; Kolb H
J Autoimmun; 1993 Aug; 6(4):405-22. PubMed ID: 8216686
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
[TBL] [Abstract][Full Text] [Related]
18. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
Reich EP; Sherwin RS; Kanagawa O; Janeway CA
Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
Verdaguer J; Yoon JW; Anderson B; Averill N; Utsugi T; Park BJ; Santamaria P
J Immunol; 1996 Nov; 157(10):4726-35. PubMed ID: 8906855
[TBL] [Abstract][Full Text] [Related]
20. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
